A Phase 3 Study of MEDI-524 (Numax) for the Prevention of RSV Disease Among Native American Indian Infants in the Southwestern United States
Phase of Trial: Phase III
Latest Information Update: 05 May 2011
At a glance
- Drugs Motavizumab (Primary)
- Indications Respiratory syncytial virus infections
- Focus Therapeutic Use
- 05 May 2011 Status changed from recruiting to completed.
- 14 May 2008 Results are presented at the Pediatric Academic Societies (PAS) Annual Meeting.
- 27 Dec 2007 Status changed from in progress to recruiting.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History